Rationale and design of the Cancer Immunotherapy Evidence Living (CIEL) Library: A continuously updated clinical trial database of cancer immunotherapies

Author:

Boesen K,Hirt J,Düblin P,Läubli H,Kassenda B,Hemkens LG,Janiaud P

Abstract

AbstractBackgroundImmunotherapies for cancers are being tested in large numbers of clinical trials. It is nearly impossible for clinicians and researchers to stay current with the evidence, and traditional systematic reviews and clinical guidelines are not suited to ensure a continued overview of all trials and their results. To address this problem, we have designed a free-to-use, and publicly available database of clinical trials that aims to be continuously updated, the Cancer Immunotherapy Evidence Living (CIEL) Library.MethodsWe aimed to include planned, ongoing, and completed interventional trials of immunotherapies for cancer, regardless of trial design (e.g., randomization, blinding, and type of comparator). We systematically searched PubMed (for published reports) andClinicalTrials.gov(for registered clinical trials). PubMed retrieved records were screened using the AI-assisted software ASReview and manually extracted and curated. We imported data fromClinicalTrials.govusing the Clinical Trials Transformation Initiative database which then requires further curation. The CIEL-Library is available and searchable via a web application (https://app.ciel-library.org/#/). It also contains the ‘Match My Patient’ feature, a patient-centered clinical decision support system, which can filter planned, ongoing or completed trials based on four patient characteristics (disease staging, previous treatments, performance status, and location). We piloted our database with one type of cancer immunotherapy, the tumor-infiltrating lymphocytes (TIL) transfer.ConclusionThe CIEL-Library offers a blueprint for a dynamic evidence synthesis infrastructure providing an exhaustive collection of clinical trials with trial characteristics and results, which can be applied across different fields, specialties, and topics. The Match My Patient search function may be very useful to implement trial research into patient-centered care by helping to find a trial for enrolment of a patient or to find results for making decisions, for example, in tumor boards.The main challenges to making a continuously updated database of clinical trials are the time and resources needed to populate it with curated and updated data. The CIEL-Library project illustrates the potential and the main limitations to designing such continuously updated trial databases that intent to be directly used in routine care.

Publisher

Cold Spring Harbor Laboratory

Reference56 articles.

1. The landscape of T cell antigens for cancer immunotherapy;Nat Cancer,2023

2. Adoptive cellular therapies: the current landscape;Virchows Arch Int J Pathol,2019

3. Cancer immunotherapy: the beginning of the end of cancer?

4. Cancer Research Institute [Internet]. [cited 2023 Dec 11]. Immuno-Oncology Landscape. Available from: https://www.cancerresearch.org/immuno-oncology-landscape

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3